Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

v3.22.2
WARRANTS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Oct. 16, 2020
Jul. 28, 2020
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Debt face amount     $ 20,000,000 $ 20,000,000 $ 20,000,000
Share-based Payment Arrangement, Tranche One [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Debt face amount   $ 20,000,000      
CFF Warrant [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants outstanding to purchase of common stock shares     1,000,000 1,000,000  
Exercise price of warrants     $ 13.20 $ 13.20  
Exercise Price of Warrants Vested     $ 13.20 $ 13.20  
Investment Agreement [Member] | CFF Warrant [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants outstanding to purchase of common stock shares     1,506,206 1,506,206  
Exercise price of warrants     $ 9.46 $ 9.46  
Weighted average remaining life of warrants       3 years 1 month 9 days  
Number of warrants exercisable for common stock       500,000  
Warrant expire date     Jan. 26, 2025 Jan. 26, 2025  
Fair value of warrants issued       $ 6,215,225  
Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants to purchase shares of common stock, exercised   86,206      
Exercise price of warrants   $ 6.96      
Loan Agreement [Member] | K2 Warrant [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants to purchase shares of common stock, exercised   86,206      
Warrants outstanding to purchase of common stock shares   86,206      
Exercise price of warrants   $ 6.96      
Warrant expire date   Jul. 28, 2030      
Fair value of warrants issued   $ 472,409      
Loan Agreement [Member] | K2 Warrant [Member] | Maximum [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Debt face amount   $ 50,000,000      
Professional Services Agreement [Member] | Warrants [Member] | Investor Relations Service Provider [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants outstanding to purchase of common stock shares 420,000        
Exercise price of warrants $ 1.07        
Fair value of warrants issued $ 334,740        
Warrant [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants to purchase shares of common stock, exercised     0 0